Back to Search Start Over

Dispersibility of phospholipids and their optimization for the efficient production of liposomes using supercritical fluid technology

Authors :
Kristofer J. Thurecht
James R. Falconer
Peter M. Moyle
Faheem Maqbool
Source :
International Journal of Pharmaceutics. 563:174-183
Publication Year :
2019
Publisher :
Elsevier BV, 2019.

Abstract

Liposomes are promising delivery vehicles and offer the added drawcard of being able to be made functional to target tissues such as cardiac muscle and cancerous cells. Current methods to manufacture liposomes need to be improved and supercritical fluid (SCF) technologies may offer a solution. Herein, the dispersibility of six different phospholipids (PLs) was determined in supercritical carbon dioxide (scCO(2)). 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) showed the highest post-processing dispersibility, while 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), and 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) showed no dispersibility in scCO2 at the assessed experimental conditions. The zetasizer results showed that the SCF conditions at 37 degrees C, 250 bar and 200 RPM for 60 min provided nanoparticles with the narrowest polydispersity index (PDI) and a spherical shape as shown by cryo-transmission electron microscopy (Cryo-TEM). The mean diameter of liposomes using the SCF method for DSPC-PEGylated and DOPC-PEGylated liposomes was 98.3 +/- 3.3 nm and 124.5 +/- 4.1 nm, while using the thin film method it was 153.6 +/- 4.5 nm and 131.3 +/- 3.4 nm, respectively. A size-based stability evaluation of the scCO(2)-prepared liposomes stored at different temperatures (25 degrees C, 4 degrees C and -20 degrees C) was compared to that of the thin film method over a period of 3 months. The current study provides a possible green alternative SCF method to preparing liposomes that is less laborious, time saving, and a low energy process.

Details

ISSN :
03785173
Volume :
563
Database :
OpenAIRE
Journal :
International Journal of Pharmaceutics
Accession number :
edsair.doi.dedup.....62fe36433c58ead2ca5bb3de73731754
Full Text :
https://doi.org/10.1016/j.ijpharm.2019.03.053